查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
豬疫苗市場規模、份額、趨勢分析報告，按產品（重組、滅活）、按類型（偽狂犬病、豬圓環病毒 2 型）、按地區、按細分市場，2022-2030 年
市場調查報告書
商品編碼
1147476

豬疫苗市場規模、份額、趨勢分析報告，按產品（重組、滅活）、按類型（偽狂犬病、豬圓環病毒 2 型）、按地區、按細分市場，2022-2030 年

Swine Vaccines Market Size, Share & Trends Analysis Report, By Product (Recombinant, Inactivated), By Type (Pseudorabies, Porcine Circovirus Type 2), By Region, and Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

豬疫苗市場的增長和趨勢

根據 Grandview Research 的一份新報告，到 2030 年，全球豬疫苗市場預計將達到 23 億美元。從 2022 年到 2030 年，該市場預計將實現 4.9% 的複合年增長率。豬病流行率和發病率的上升、對人畜共患疾病的關注增加以及養豬場生物安全措施的增加是推動市場增長的一些主要因素。此外，政府和動物保健組織為傳播疾病意識和支持疫苗接種所做的努力進一步推動了預測期內的市場增長。

COVID-19 大流行直接或間接影響了主要參與者的豬疫苗業務運營，最初導致財務業績不佳。由於各種生產和供應鏈瓶頸導致大流行的影響，必要的原材料和活性成分的供應被推遲，某些研發活動被推遲。但與此同時，多個地區爆發非洲豬瘟疫情，對豬用疫苗生產企業提出了巨大需求。 2020 年，OIE 報告稱亞洲爆發了 9,928 起 ASF，其次是歐洲爆發了 4,271 起。鑑於這種情況，政府因此藉機放鬆管制並支持豬疫苗的分銷並重組公司的增長。

此外，在農業和獸醫領域，全球範圍內對抗生素耐藥性的擔憂日益加劇。因此，一些國家已禁止在畜牧業中使用抗生素，包括預防性治療。法律強制養豬場採用非抗生素疾病預防方法，例如接種疫苗。此外，主要參與者為開發先進產品以進行更好的診斷而進行的投資可能會推動市場增長。例如，2020 年 5 月，Indian Immunologicals Ltd. 推出了品牌名為“Raksha Class”的經典豬瘟疫苗，這是一種基於與印度獸醫研究所 Bareilly 合作開發的專有細胞培養技術的疫苗。

市場參與者正在實施各種戰略舉措，例如收購、合併、合作夥伴關係和產品發布，以保持市場競爭力。例如，2022 年 3 月，Ceva 推出了豬疫苗，這是一種含有七種抗原的疫苗，用於治療新生兒腹瀉。

豬疫苗市場報告要點

由於主要養豬國家的大流行，2021 年 PRRS（豬繁殖與呼吸綜合徵）細分市場在該類型細分市場中的銷售額份額最大。該病在美國流行了30多年，在養豬大國中國也流行了20多年。

按產品劃分，滅活疫苗細分市場將在 2021 年佔據最大的市場份額。這些疫苗比減毒活疫苗更穩定，可以為豬提供更好的免疫力。它還可以防止病原體複製，因此不存在毒力再次出現的風險。

亞太地區預計將在 2021 年佔據最大的市場份額，並以最快的複合年增長率增長。這一顯著份額主要是由於中國等主要生豬生產國的存在、龐大的肉類消費人口，以及對控制當前亞洲豬群疾病爆發的疫苗的廣泛需求。

這個市場與 Zoetis、Merck、Ceva、Boehringer Ingelheim International GmbH、Elanco 和 Virbac 等大公司競爭激烈。公司採取的各種戰略舉措，如收購、聯盟、產品發布和合作夥伴關係，為市場的增長做出了重大貢獻。

內容

第 1 章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 資訊採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
    • 初步調查的詳細資訊
  • 資訊和數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析
      • 自下而上的市場預測
      • 自上而下的市場預測
    • 全球市場：CAGR 計算
  • 次要信息列表

第 2 章執行摘要

  • 豬疫苗市場展望
    • 細分市場展望
    • 區域展望
    • 競爭前景
  • 2021 年豬疫苗市場概況

第 3 章豬疫苗市場變量、趨勢和範圍

  • 市場系列展望
    • 母市場分析
    • 補充市場分析
  • 滲透率和增長前景圖，產品類型，2021 年
  • 豬疫苗市場動態
    • 市場促進因素分析
      • 對人畜共患疾病的日益關注和加強生物安全
      • 疫苗可替代抗生素
      • 技術進步
      • 監管義務
    • 市場抑制因素分析
      • 產品獨占期短
      • 宗教和文化限制
      • 禁止供應生豬和豬肉產品
  • 行業分析
    • 波特的分析
      • 新進入者的威脅：中低
      • 替代品的威脅：中到高
      • 買家的議價能力：中等
      • 供應商的議價能力：低
      • 競爭對手之間的敵意：高
    • PESTEL 分析
      • 政治和法律格局
      • 經濟的
      • 社交
      • 技術
      • 環境
  • 監管框架
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 世界其他地方
  • 產品管道分析

第 4 章豬疫苗市場：Covid-19 影響分析

  • Covid-19 影響分析

第 5 章按產品分類的估計和趨勢分析，2017-2030（百萬美元）

  • 2017-2030 年產品差異分析（百萬美元）
  • 2021 年和 2030 年豬疫苗市場份額分析
    • 減毒活疫苗
    • 滅活□□疫苗
    • 亞單位疫苗
    • DNA疫苗
    • 重組疫苗

第 6 章按類型估算和趨勢分析，2017-2030（百萬美元）

  • 2017-2030 年類型變化分析（百萬美元）
  • 2021 年和 2030 年豬疫苗市場份額分析
    • 豬流感
    • 不丹熱
    • 豬細小病毒
    • 2 型豬圓環病毒
    • 豬肺炎支原體
    • 胸膜肺炎放線桿菌
    • 藍耳病
    • 手足口病
    • 偽狂犬病
    • 豬流行性腹瀉
    • 其他

第 7 章2017 年至 2030 年各地區的估計和趨勢（百萬美元）

  • 區域市場概況
  • 2021 年和 2030 年區域市場份額分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 西班牙
    • 意大利
    • 英國
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯

第 8 章競爭格局

  • 市場參與分類
  • 上市公司
    • 公司市場分析
    • 熱圖分析
  • 私人公司
    • 主要公司名單

第 9 章豬疫苗市場 - 公司概況

  • Merck &Co., Inc.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Ceva
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Zoetis
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Boehringer Ingelheim International GmbH
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Elanco
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Indian Immunologicals Ltd.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Biogenesis Bago
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Phibro Animal Health Corporation
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • KM Biologics（Meiji Holdings Co., Ltd）
    • 公司簡介
    • 財務業績
    • 產品基準
  • HIPRA
    • 公司簡介
    • 產品基準
    • 戰略舉措
  • Virbac
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
Product Code: GVR-4-68039-728-0

Swine Vaccines Market Growth & Trends:

The global swine vaccines market size is expected to reach USD 2.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness a lucrative CAGR of 4.9% from 2022 to 2030. The increasing prevalence and incidence of swine diseases, rising concerns over zoonoses, and strengthening biosecurity measures among swine farms are some of the major factors augmenting the market growth. In addition, the initiatives taken by government and animal healthcare organizations in spreading disease awareness and supporting vaccination drives are further propelling the market growth during the projected period.

The Covid-19 pandemic has directly or indirectly impacted the key player's swine vaccine business operations and resulted in declined financial performance during the initial time. The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, the simultaneously reported African swine fever outbreaks in several regions pressured the swine vaccine manufacturers with a large demand. In 2020, the OIE reported 9,928 ASF outbreaks in Asia, followed by 4,271 outbreaks in Europe. Hence, considering the situation, the government supported the distribution of swine vaccines with ease of restrictions, which afforded opportunities to rebuild the company's growth.

In addition, the global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Thus, several countries have banned the use of antibiotics for livestock farming, including preventive treatment procedures. This act has compelled swine farms to adopt antibiotic-free disease preventive approaches such as vaccination. Furthermore, growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine under the brand name 'Raksha Class', a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players in the market are implementing various strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, In March 2022, Ceva launched the sow vaccine, a vaccine containing seven antigens used to treat neonatal diarrhea.

Swine Vaccines Market Report Highlights:

  • The PRRS (Porcine Reproductive and Respiratory Syndrome) segment accounted for the largest revenue share in 2021 by type segment owing to its large prevalence in major swine-raising countries. The disease has been considered an epidemic for over 30 years in the U.S. and more than 20 years in China, the leading swine industry
  • By product, the inactivated vaccines segment held the largest market share in 2021. These vaccines are more stable than live attenuated vaccines and can provide swine with better immunization. They prevent pathogen replication and therefore do not possess the risk of virulence reversion
  • Asia Pacific accounted for the largest market share in 2021 and is expected to grow at the fastest CAGR. Key factors contributing to this notable share include the presence of leading swine production countries such as China coupled with a large meat-consuming population and wide requirement for vaccines to curb current rising disease outbreaks among Asian swine herds
  • The market is fairly competitive owing to the presence of major players such as Zoetis, Merck, Ceva, Boehringer Ingelheim International GmbH, Elanco, and Virbac among others. The various strategic initiatives implemented by companies such as acquisitions, collaborations, product launches, and partnerships are greatly contributing to the growth of the market

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information/Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Bottom - Up Market Estimation
      • 1.6.1.2 Top - Down Market Estimation
    • 1.6.2 Global Market: Cagr Calculation
  • 1.7 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Swine Vaccines Market Outlook
    • 2.1.1 Segment Outlook
    • 2.1.2 Regional Outlook
    • 2.1.3 Competitive Outlook
  • 2.2 Swine Vaccines Market Snapshot, 2021

Chapter 3 Swine Vaccines Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration And Growth Prospect Mapping, By Product Type, 2021
  • 3.3 Swine Vaccines Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising Concern About Zoonoses & Strengthening Biosecurity
      • 3.3.1.2 Vaccines Act As An Alternative To Antibiotics
      • 3.3.1.3 Technological Advancements
      • 3.3.1.4 Regulatory Mandates
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Short Product Exclusivity Period
      • 3.3.2.2 Religious And Cultural Restrictions
      • 3.3.2.3 Supply Bans On Live Pigs And Pork Products
  • 3.4 Industry Analysis
    • 3.4.1 Porter's Analysis
      • 3.4.1.1 Threat Of New Entrants: Low - Moderate
      • 3.4.1.2 Threat Of Substitutes: Moderate To High
      • 3.4.1.3 Bargaining Power Of Buyers: Moderate
      • 3.4.1.4 Bargaining Power Of Suppliers: Low
      • 3.4.1.5 Competitive Rivalry: High
    • 3.4.2 Pestel Analysis
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic
      • 3.4.2.3 Social
      • 3.4.2.4 Technological
      • 3.4.2.5 Environmental
  • 3.5 Regulatory Framework
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Apac
    • 3.5.4 Latam
    • 3.5.5 Rest Of The World
  • 3.6 Product Pipeline Analysis

Chapter 4 Swine Vaccines Market: Covid - 19 Impact Analysis

  • 4.1 Covid - 19 Impact Analysis

Chapter 5 Product Estimates & Trend Analysis, 2017 - 2030 (USD Million)

  • 5.1 Product Movement Analysis, 2017 - 2030 (USD Million)
  • 5.2 Swine Vaccines Market Share Analysis, 2021 & 2030
    • 5.2.1 Attenuated Live Vaccines
      • 5.2.1.1 Attenuated Live Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.2.2 Inactivated Vaccines
      • 5.2.2.1 Inactivated Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.2.3 Subunit Vaccines
      • 5.2.3.1 Subunit Vaccines Market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.2.4 Dna Vaccines
      • 5.2.4.1 Dna Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.2.5 Recombinant Vaccines
      • 5.2.5.1 Recombinant Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Type Estimates & Trend Analysis, 2017 - 2030 (USD Million)

  • 6.1 Type Movement Analysis, 2017 - 2030 (USD Million)
  • 6.2 Swine Vaccines Market Share Analysis, 2021 & 2030
    • 6.2.1 Swine Influenza
      • 6.2.1.1 Swine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.2 Classical Swine Fever
      • 6.2.2.1 Classical Swine Fever Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.3 Porcine Parvovirus
      • 6.2.3.1 Porcine Parvovirus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.4 Porcine Circovirus Type 2
      • 6.2.4.1 Porcine Circovirus Type 2 Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.5 M.Hyo
      • 6.2.5.1 M.Hyo Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.6 Actinobacillus Pleuropneumonia
      • 6.2.6.1 Actinobacillus Pleuropneumonia Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.7 PRRS
      • 6.2.7.1 PRRS Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.8 Foot & Mouth Disease
      • 6.2.8.1 Foot & Mouth Disease Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.9 Pseudorabies
      • 6.2.9.1 Pseudorabies Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.10 Porcine Epidemic Diarrhea
      • 6.2.10.1 Pedv Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.2.11 Others
      • 6.2.11.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 7 Regional Estimates & Trend Analysis, 2017 - 2030 (USD Million)

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 North America
    • 7.3.1 North America Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Canada Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.2 France
      • 7.4.2.1 France Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Germany Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.4 Spain
      • 7.4.4.1 Spain Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.5 Italy
      • 7.4.5.1 Italy Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.4.6 U.K.
      • 7.4.6.1 UK Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.5.2 India
      • 7.5.2.1 India Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.5.4 Japan
      • 7.5.4.1 Japan Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Australia Swine Vaccines Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 South Korea Swine Vaccines Market Estimates and Forecasts, 2017 - 2030 (USD million)
  • 7.6 Latin America
    • 7.6.1 Latin America Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Mexico Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Argentina Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Swine Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 South Africa Swine Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Saudi Arabia Swine Vaccines Market estimates and forecasts 2017 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Market Participation Categorization
  • 8.2 Public Companies
    • 8.2.1 Company Market Position Analysis
    • 8.2.2 Heat Map Analysis
  • 8.3 Private Companies
    • 8.3.1 List Of Key Companies

Chapter 9 Swine Vaccines Market - Company Profiles

  • 9.1 Merck & Co., Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Benchmarking
    • 9.1.4 Strategic Initiatives
  • 9.2 Ceva
    • 9.2.1 Company Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Benchmarking
    • 9.2.4 Strategic Initiatives
  • 9.3 Zoetis
    • 9.3.1 Company Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Benchmarking
    • 9.3.4 Strategic Initiatives
  • 9.4 Boehringer Ingelheim International GmbH
    • 9.4.1 Company Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Benchmarking
    • 9.4.4 Strategic Initiatives
  • 9.5 Elanco
    • 9.5.1 Company Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Benchmarking
    • 9.5.4 Strategic Initiatives
  • 9.6 Indian Immunologicals Ltd.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Benchmarking
    • 9.6.4 Strategic Initiatives
  • 9.7 Biogenesis Bago
    • 9.7.1 Company Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Benchmarking
    • 9.7.4 Strategic Initiatives
  • 9.8 Phibro Animal Health Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Benchmarking
    • 9.8.4 Strategic Initiatives
  • 9.9 KM Biologics (Meiji Holdings Co., Ltd)
    • 9.9.1 Company Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Benchmarking
  • 9.10 HIPRA
    • 9.10.1 Company Overview
    • 9.10.2 Product Benchmarking
    • 9.10.3 Strategic Initiatives
  • 9.11 Virbac
    • 9.11.1 Company Overview
    • 9.11.2 Financial Performance
    • 9.11.3 Product Benchmarking
    • 9.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 North America Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 3 North America Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 4 U.S. Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 5 U.S. Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 6 Canada Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 7 Canada Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 8 Europe Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 9 Europe Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 10 U.K. Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 11 U.K. Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 12 Germany Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 13 Germany Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 14 France Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 15 France Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 16 Italy Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 17 Italy Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 18 Spain Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 19 Spain Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 20 Asia Pacific Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 21 Asia Pacific Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 22 Japan Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 23 Japan Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 24 China Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 25 China Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 26 India Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 27 India Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 28 Australia Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 29 Australia Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 30 South Korea Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 31 South Korea Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 32 Latin America Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 33 Latin America Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 34 Brazil Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 35 Brazil Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 36 Mexico Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 37 Mexico Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 38 Argentina Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 39 Argentina Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 40 MEA Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 41 MEA Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 42 South Africa Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 43 South Africa Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 44 Saudi Arabia Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 45 Saudi Arabia Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)
  • Table 46 Global Swine Vaccines market revenues, by type, 2017 - 2030 (Revenue, USD Million)
  • Table 47 Global Swine Vaccines market revenues, by product, 2017 - 2030 (Revenue, USD Million)

List of Figures

  • Fig. 1 Swine Vaccines market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value - chain - based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 General methodology for a Commodity flow analysis of Animal Health markets
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Swine Vaccines Market Snapshot (2021, USD Million)
  • Fig. 11 Parent market outlook
  • Fig. 12 Ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping, by product type, 2021
  • Fig. 14 Swine Vaccines market dynamics analysis
  • Fig. 15 Swine Vaccines market driver analysis
  • Fig. 16 Swine Vaccines market restraint impact
  • Fig. 17 Swine vaccines market: Product movement analysis, 2017 - 2030 (USD Million)
  • Fig. 18 Swine vaccines market share analysis, 2021 & 2030
  • Fig. 19 Attenuated live vaccines market, 2017 - 2030 (USD Million)
  • Fig. 20 Inactivated vaccines market, 2017 - 2030 (USD Million)
  • Fig. 21 Subunit vaccines market, 2017 - 2030 (USD Million)
  • Fig. 22 DNA vaccines market, 2017 - 2030 (USD Million)
  • Fig. 23 Recombinant vaccines market, 2017 - 2030 (USD Million)
  • Fig. 24 Swine vaccines market: Type movement analysis, 2017 - 2030 (USD Million)
  • Fig. 25 Swine vaccines market share analysis, 2021 & 2030
  • Fig. 26 Swine influenza market, 2017 - 2030 (USD Million)
  • Fig. 27 Classical swine fever market, 2017 - 2030 (USD Million)
  • Fig. 28 Porcine parvovirus market, 2017 - 2030 (USD Million)
  • Fig. 29 Porcine circovirus type 2 market, 2017 - 2030 (USD Million)
  • Fig. 30 M.Hyo market, 2017 - 2030 (USD Million)
  • Fig. 31 Actinobacillus pleuropneumonia market, 2017 - 2030 (USD Million)
  • Fig. 32 PRRS market, 2017 - 2030 (USD Million)
  • Fig. 33 Foot & mouth disease market, 2017 - 2030 (USD Million)
  • Fig. 34 Pseudorabies market, 2017 - 2030 (USD Million)
  • Fig. 35 PEDV market, 2017 - 2030 (USD Million)
  • Fig. 36 Others market, 2017 - 2030 (USD Million)
  • Fig. 37 Regional Market Snapshot
  • Fig. 38 Regional Market Share Analysis, 2021 & 2030
  • Fig. 39 Swine Population in North America (Unit in heads)
  • Fig. 40 North America Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 41 U.S. Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 42 Canada Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 43 Europe Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 44 France Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 45 Germany Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 46 Swine population in Spain (Unit in heads)
  • Fig. 47 Spain Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 48 Italy Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 49 U.K. Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 50 Swine population in Asia Pacific (in Millions of heads)
  • Fig. 51 Asia Pacific Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 52 India Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 53 Swine population in China (in Millions of heads)
  • Fig. 54 China Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 55 Japan Swine Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 56 Latin America swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 57 Swine population in Brazil (estimated), 2017 - 2021 (in Millions of heads)
  • Fig. 58 Brazil swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 59 Estimated Swine population in Mexico, 2017 - 2021 (Units in Heads)
  • Fig. 60 Mexico swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 61 Estimated Swine population in Argentina, 2017 - 2021 (Units in Heads)
  • Fig. 62 Argentina swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 63 MEA swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 64 Estimated Swine population in South Africa, 2017 - 2021 (Units in Heads)
  • Fig. 65 South Africa swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia Swine Vaccines Market, 2017 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Swine vaccines market, 2017 - 2030 (USD Million)
  • Fig. 68 Market participation categorization
  • Fig. 69 Market leaders and innovators
  • Fig. 70 Public company market position analysis